1. Catalogs
  2. Spineart
  3. BAGUERA ® C
video corpo

BAGUERA ® C

BAGUERA ® C

Product catalog summary
Study Overview: This document summarizes a two-year prospective clinical follow-up study on the BAGUERA® C cervical disc prosthesis, conducted in Europe. The study is not FDA approved and is intended for registration in various countries.
Primary Objectives:
  • Safety Evaluation: The study aimed to evaluate the safety of the BAGUERA® C prosthesis by analyzing all adverse events reported during the two-year post-operative period, regardless of their relation to the device.
  • Effectiveness Evaluation: The overall success rate was determined by a composite primary endpoint based on five parameters: functional improvement, neurological improvement, pain relief, quality of life improvement, and absence of subsequent surgery.
Indication: The study focused on patients with symptomatic cervical degenerative disc disease at one or two levels from C3 to C7.
Study Type: This was an observational, prospective data collection study with retrospective analysis, conducted as a multicenter cohort study.
Patients Enrolled: 118 patients participated in the study.
Primary Outcomes:
  • NDI Scores: Evaluated for functional improvement.
  • Adverse Events: Detailed analysis of duration, seriousness, intensity, severity, and relationship to the implant and surgery, including any re-interventions or revisions.
  • Neck and Arm Pain: Assessed using the Visual Analog Scale (VAS).
  • Neurological Status: Evaluated for motor functions, reflexes, and sensibility.
  • SF-36 Scores: Used to assess improvements in health-related quality of life.
See more

Catalog excerpts

BAGUERA ® C-1

BAGUERA®C Study #16001 Cervical Arthroplasty using BAGUERA® C: A two-year, prospective, clinical follow-up data registry. Retrospective clinical analysis results Not FDA approved. Non-US study Region: Europe Status: Completed Pilot study for registration in various countries Primary Objectives: Safety Evaluation: Evaluation at the end of 2 years post-operative follow-up of the safety of the BAGUERA®C cervical disc prosthesis by analyzing all adverse events reported during the observation period, whether anticipated or unanticipated, related or not to the use of the device. Effectiveness Evaluation: An overall success rate was defined as a composite primary endpoint, based on individual overall success evaluated for each subject at 24 months post-operative, based on five parameters taken from clinical and safety evaluation: 1. Functional improvement of 20% at 24 months post-operative, compared to the pre-operative status, evaluated by the Neck Disability Index (NDI). 2. Neurological improvement: conservation of or improvement in three main components of the neurological status: motor functions, reflexes, sensibility. 3. Neck and Arm Pain: pain relief of 20% at 24 months post-operative, compared to the pre-operative status, evaluated by VAS scores. 4. Improvement in Health-related Quality of Life of 15% at 24 months postoperative, compared to the pre-operative status, assessed using the Short-Form36 questionnaire (SF-36 scores) 5. No subsequent surgery. Indication - condition: Symptomatic cervical degenerative disc disease one or two levels from C3 to C7 Study type: Observational, prospective data collection (registry), retrospective analysis, multicenter cohort study Patients enrolled: 118 Primary outcomes: • NDI scores • Adverse events: - Duration (starts and end dates), - Seriousness, Intensity, Severity, Anticipated/Unanticipated - Relationship to the implant (suspected/not suspected), - Re-interventions, Revisions, - Relationship to the surgery (suspected/not suspected), - Removals or supplemental fixation. • Neck and Arm Pain by Visual Analogic Scale (VAS) • Neurological status: motor functions, reflexes, sensibility • SF-36 scores

 Open the catalog to page 1

All Spineart catalogs and technical brochures

  1. JULIET®AN

    1  Page

  2. JULIET ® OL

    2  Pages

  3. TRYPTIK ® CA

    2  Pages

  4. JULIET® PO

    2  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.